Feedback PLC Bleepa - the clinical messaging app - at NHS Expo

TIDMFDBK

Feedback PLC

04 September 2019

Feedback plc

Bleepa(TM) - the revolutionary clinical messaging app - showcased at NHS Expo 2019

Feedback Medical unveils ground-breaking medical imaging product

Cambridge, 4 September 2019: As previously announced, Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is unveiling its new revolutionary clinical messaging product, Bleepa(TM) , to over 6,000 conference delegates at NHS Expo in Manchester on 4-5 September 2019.

Dr Tom Oakley, CEO of Feedback, commented:

"We are demonstrating Bleepa(TM) for the first time at Expo with leaders who are driving digital innovation across the NHS. The role of digital technology in revolutionising patient care is central to the NHS Long Term Plan and we believe Bleepa(TM) sits firmly at the heart of this movement, enabling clinicians to share high quality medical images and discuss how to give the best possible patient care securely and quickly via mobile devices."

Bleepa(TM) is an innovative new app based on Feedback's Cadran technology, which allows medical staff to securely view and discuss high quality medical grade images on mobile devices. The app will display images directly from the hospital's Picture Archive Communication System (PACS). Bleepa(TM) can display any type of image including X-rays, CTs, MRIs and ultrasound studies allowing users to easily scroll through image slices and annotate areas of interest. Questions can be asked alongside annotations and submitted into the chat where they can be securely reviewed by colleagues at the swipe of a finger, with instant access to the original image.

Bleepa(TM) enables faster clinical decisions as doctors will be able to share, review and discuss images including screen sharing with multiple staff, both accelerating and improving patient care. All data and resulting decisions will be stored in hospital records for later review.

Currently, it is only possible to view medical grade images on desktop computers and discuss them by telephone. According to BMJ Innovations, 97% of hospital doctors routinely use WhatsApp to communicate about patients.(1) This increasing trend for clinicians to use personal devices to discuss patient care and make clinical decisions is more convenient and efficient than traditional methods of clinical communication. However, these images are not of sufficient quality to make clinical decisions and sharing data in this way breaches data protection legislation, leaving hospitals and individual staff open to the risk of litigation.

The Directors believe Bleepa(TM) will be the leading communication tool on the market and will be a CE marked medical device.

Bleepa(TM) will be demonstrated and available for pre-order on stand 29 at NHS England Health and Care Innovation Expo at Manchester Central, 4 - 5 September 2019. For more information see www.bleepa.com.

(1) O'Sullivan DM, O'Sullivan E, O'Connor M, et al WhatsApp Doc? BMJ Innovations 2017;3:238-239.

-Ends-

Enquiries:

 
 Feedback plc                      [phone] 
  Tom Oakley, CEO                   [e-mail] 
  Lindsay Melvin, CFO 
 
 Instinctif Partners               [phone] 
  Rozi Morris / Phillip Marriage    [e-mail] 
 

Notes to editors

About Feedback plc - www.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

Feedback has launched Bleepa(TM) , a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa(TM), see www.bleepa.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRAUOSBRKKAKRAR

(END) Dow Jones Newswires

September 04, 2019 02:01 ET (06:01 GMT)